Replies to post #323681 on Avid Bioservices Inc (CDMO)

[vinmantoo]

i don’t think 19 patients were dosed. not sure your stats are accurate. irrelevant anyway today.

We still have not heard about the 19 patients of 22 for Yervoy + Bavituximab

Don't you see the puzzle piece in that? See, all those patients did fantastically well and are still alive years after they should have been dead. It was the most amazing results ever seen. Big Pharma saw that this was the game changer of all game changers and a threat to their very existence. Therefore they did the only thing possible to ensure their survival. They all met in a small house outside of Fantasyland, Indiana and unanimously decided to suppress the data so that they can keep driving PPHM/CDMO price down. Otherwise one of them would have had to buy PPHM/CDMO for around $200 million, and that price would obviously bankrupt any company even though it would get them the game changer of all game changers.

[InternetForumUser]

According to the Clinical Trials site. only 3 Patients were actually enrolled for that Terminated Trial. Where did you get that there were 19 patients enrolled?

 
 Actual Enrollment  :	3 participants 
 Allocation:	Randomized 
 Intervention Model:	Parallel Assignment 
 Masking:	None (Open Label) 
 Primary Purpose:	Treatment 
 Official Title:	A Two-Arm, Single Center Pase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients 
 Study Start Date  :	April 2014 
 Primary Completion Date  :	April 2016 
 Study Completion Date  :	April 2016